Лучевые и электрофизиологические предикторы нарушения атриовентрикулярной проводимости у больных с синдромом слабости синусового узла (стр. 13 )

98. Ishikawa T., Sumita S., Kosuge M. et al. Reducing ventricular pacing in sinus node dysfunction. // Int Heart J. – 2007,May. – №48(3). – P.323–336.

99. Isobe M. Familial sick sinus syndrome with atrioventricular conduction disturbance./M. Isobe et al. //Jpn Circ J 1998 Oct;: 788 – 790.

100. Issa Z., Miller J. M., Zipes D. P. Clinical Arrhythmology and Electrophysiology: A Companion to Braunwald's Heart Disease. - Elsevier Health Sciences. – 2008. – 502p.

101. Jones S. A. Ageing to arrhythmias: conundrums of connections in the ageing heart. // J Pharm Pharmacol. – 2006,Dec. – №58(12). – P.1571–1576.

102. Kaplan B. M., Langendorf R., Lev M., Pick A. Tachycardia-bradycardia syndrome (so-called "sick sinus syndrome"). Pathology, mechanisms and treatment. // Am J Cardiol. – 1973. - №31. – P.497.

103. Kardelen F., Celiker A., Ozer S. et al. Sinus node dysfunction in children and adolescents: treatment by implantation of a permanent pacemaker in 26 patients. // Turk J Pediatr. – 2002,Oct–Dec. – №44(4). –P.312–316.

104. Kastor J. A., Desanctis R. W., Leinbach R. C. et al. Long–Term Pervenous Atrial Pacing. // Circulation. – 1969. – №40. – P.535–544.

105. Kato M., Dote K., Sasaki S. et al. Determination of the optimal atrioventricular interval in sick sinus syndrome during DDD pacing. // Pacing Clin Electrophysiol. – 2005,Sep. – №28(9). – P.892–897.

106. Kaźmierczak J. Electrophysiological characteristics of the heart with special reference to the sinoatrial node function in patients with disorders of the atrioventricular and intraventricular conduction. // Ann Acad Med Stetin. – 1992. – №38. – P.157–171.

107. Körber T., Voss W., Ismer B. et al. Feasibility and safety of long–term AAI(R) pacing in isolated sinus node syndrome. // Herzschrittmacherther Elektrophysiol. – 2006,Mar. – №17(1). – P.19–25.

108. Kosakai Y., Ohe Т., Kamakura S. Long-term follow-up of incidence of embolism in sick sinus syndrome after pacing. // PACE№ 14. - P.680.

109. Kristensen L., Nielsen J. C., Pedersen A. K. et al. AV block and changes in pacing mode during long–term follow–up of 399 consecutive patients with sick sinus syndrome treated with an AAI/AAIR pacemaker. // Pacing Clin Electrophysiol. – 2001. – №24(3). – P.358–365.

110. Lamas G., Lee K., Sweeney M. The Mode Selection Trial (MOST) in sinus node dysfunction: design, rationale, and baseline characteristics of the first 1000 patients. // American Heart J№ 000. - P.541-551.

111. Lamas G. A., Lee K. L., Sweeney M. O. et al. Ventricular pacing or dual–chamber pacing for sinus–node dysfunction; Mode Selection Trial in Sinus–Node Dysfunction. // N Engl J Med. – 2002,Jun. – vol.13. – № 000(24). – P.1854–1862.

112. Le Scouarnec S., Bhasin N., Vieyres C. et al. Dysfunction in ankyrin–B–dependent ion channel and transporter targeting causes human sinus node disease. // Proc Natl Acad Sci U S A. – 2008,Oct. – vol.7. – № 000(40). – P.15617–15622.

113. Lemke B., Hoeltmann B. J., Selbach H., Barmeyer J. The atrial pacemaker as therapy in sinus node disease: retrospective analysis of сomplications and rate of survival. // Z Kardiol. – 1987,Aug. – №76(8). – P.484–491.

114. Liang K. W., Lee W. L., Hsueh C. W. et al. Atrial demand pacemakers in sick sinus syndrome: an efficient and reliable approach in selected patients. // J Chin Med Assoc. – 2003,Dec. – №66(12). – P.709–714.

115. Link M. S., Hellkamp A. S, Estes M. N.A. et al. High incidence of pacemaker syndrome in patients with sinus node dysfunction treated with ventricular–based pacing in the Mode Selection Trial (MOST). // J Am Coll Cardiol. – 2004. – №43. – P.2066–2071.

116. Liu W. H., Chen M. C., Chen Y. L. et al. Right ventricular apical pacing acutely impairs left ventricular function and induces mechanical dyssynchrony in patients with sick sinus syndrome: a real–time three–dimensional echocardiographic study. // J Am Soc Echocardiogr. – 2008,Mar. – №21(3). – P.224–229.

117. Lown B. Electrical reversion of cardiac arrhythmias. // Br Heart J. – 1967. - №29. – P.469.

118. Mani H., Shirayama T., Suzaki Y. et al. Clinical significance of preserving spontaneous QRS wave in the therapy of DDD pacing for sick sinus syndrome. // Pacing Clin Electrophysiol. – 2004,Sep. – №27(9). – P.1212–1216.

119. Marketou M. E., Simantirakis E. N., Prassopoulos V. K. et al. Assessment of myocardial adrenergic innervation in patients with sick sinus syndrome: effect of asynchronous ventricular activation from ventricular apical stimulation. // Heart. – 2002,Sep. – №88(3). – P.255–259.

120. Masumoto H., Ueda Y., Kato R. et al. Long–term clinical performance of AAI pacing in patients with sick sinus syndrome: a comparison with dual–chamber pacing. // Europace. – 2004,Sep. – №6(5). – P.444–450.

121. Medzevicius A., Medzeviciene V. Atrioventricular conduction and permanent atrial pacing. // Medicina (Kaunas). – 2002. – №38(1). – P.43–46.

122. Melzer C., Sowelam S., Sheldon T. J. et al. Reduction of right ventricular pacing in patients with sinus node dysfunction using an enhanced search AV algorithm. // Pacing Clin Electrophysiol. – 2005.Jun. – №28(6). – P.521–527.

123. Milasinovic G., Tscheliessnigg K., Boehmer A. et al. Percent ventricular pacing with managed ventricular pacing mode in standard pacemaker population. // Europace. – 2008,Feb. – №10(2). – P.151–155.

124. Moríñigo J. L., Arribas A., Ledesma C. et al. Clinical safety and efficacy of single–chamber atrial pacing in sick sinus syndrome: long–term follow–up. // Rev Esp Cardiol. – 2002,Dec. – №55(12). – P.1267–1272.

125. Moro E., Caprioglio F., Berton G. et al. DDD versus VVIR versus VVI mode in patients with indication to dual–chamber stimulation: a prospective, randomized, controlled, single–blind study. // Ital Heart J. – 2005,Sep. – №6(9). –P.728–733.

126. Moss A. J., Rivers R. J.Jr. Atrial pacing from the coronary vein. Ten–year experience in 50 patients with implanted pervenous pacemakers. // Circulation. – 1978,Jan. – №57(1). – P.103–106.

127. Musilli N., Padeletti L. Pacemaker selection: time for a rethinking of complex pacing systems? // Eur Heart J. – 2006,Jan. – №27(2). – P.132–135.

128. Naegeli B., Kurz D. J., Koller D. et al. Single–chamber ventricular pacing increases markers of left ventricular dysfunction compared with dual–chamber pacing. // Europace. – 2007,Mar. – №9(3). – P.194–199.

129. Nahlawi M., Waligora M., Spies S. M. et al. Left ventricular function during and after right ventricular pacing. // J Am Coll Cardiol. – 2004,Nov. – vol.2. – №44(9). – P.1883–1888.

130. Nichols G. A., Reinier K., Chugh S. S. Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation. // Diabetes Care. – 2009. – Oct. – vol.10. - №32. – P..

131. Nielsen J. C. Pacing mode selection in patients with sick sinus syndrome. // Dan Med Bull. – 2007,Feb. – №54(1). – P.1–17.

132. Nielsen J. C., Bøttcher M., Nielsen T. T. et al. Regional myocardial blood flow in patients with sick sinus syndrome randomized to long–term single chamber atrial or dual chamber pacing–effect of pacing mode and rate. // J Am Coll Cardiol. – 2000,May. – №35(6). – P.1453–1461.

133. Nielsen J. C., Kristensen L., Andersen H. R. et al. A randomized comparison of atrial and dual–chamber pacing in 177 consecutive patients with sick sinus syndrome: echocardiographic and clinical outcome. // J Am Coll Cardiol. – 2003,Aug. – №42(4). – P.614–623.

134. Nielsen J. C., Pedersen A. K., Mortensen P. T., Andersen H. R. Programming a fixed long atrioventricular delay is not effective in preventing ventricular pacing in patients with sick sinus syndrome. // Europace. – 1999,Apr. – №1(2). – P.113–120.

135. Ogawa H., Ishikawa T., Matsushita K. et al. Effects of right atrial pacing preference in prevention of paroxysmal atrial fibrillation: Atrial Pacing Preference study (APP study). // Circ J. – 2008,May. –№72(5). – P.700–704.

136. Parsonnet V. Techniques for permanent transvenous pacemaker implantation: personal preferences. // Proc. of the Vllth World Symp. on cardiac pacing, ViennaP.441-447

137. Pietrucha A. Z., Wnuk M., Wojewódka–Zak E. Evaluation of sinus and atrioventricular nodes function in patients with vasovagal syncope. // Pacing Clin Electrophysiol. – 2009,Mar. – №32,Suppl 1. – P.158–162.

138. Pistolese M., Boccadamo R., Altamura G. The criteria for the choice of a cardiac pacemaker. // G Ital Cardiol. – 1978. - №8, Suppl 1. – P.71-80.

139. Psychari S. N., Apostolou T. S., Iliodromitis E. K. et al. DDDR pacing results in left ventricular asynchrony with preservation of ejection fraction and NT–proBNP: A prospective study in sick sinus syndrome and normal ventricular function. // Int J Cardiol. – 2009,Apr.

140. Pürerfellner H., Brandt J., Israel C. et parison of two strategies to reduce ventricular pacing in pacemaker patients. // Pacing Clin Electrophysiol. – 2008,Feb. – №31(2). – P.167–176.

141. Raviele A., Di Pede F., Zuin G. et al. Clinical significance of corrected sinus node recovery time and natural and unnatural history of sinus node dysfunctions. A four–year prospective follow–up of 101 cases. // G Ital Cardiol. – 1982. – №12(8). P.563–574.

142. Reiter M. J., Harsch M., Lung T. H. et al. Influence of structural heart disease on characteristics of atrial fibrillation recurrence in patients with dual–chamber pacemakers. – J Electrocardiol. – 2009,Mar–Apr. – №42(2). – P.128–135.

143. Renggli J.// Schweiz. med. WschrBd 106. - S. 615-619

144. Ricci R., Pignalberi C., Santini L. et al. Physiologic pacing for atrial fibrillation prevention in sinus node disease: long–term results. // Pacing Clin Electrophysiol. – 2006,Dec. – №29(2). – P.54–60.

145. Rinfret S., Cohen D. J., Lamas G. A. et al. Cost–effectiveness of dual–chamber pacing compared with ventricular pacing for sinus node dysfunction. // Circulation. – 2005,Jan. – vol.18. – № 000(2). –P.165–172.

146. Rosenberg M. S., Sessions R. W., Graettinger J. S. Stokes–Adams attacks due to atrial arrest: Management by permanent atrial or ventricular pacemakers. // Circulation. – 1966. №33–4(suppl III). – P. III–201.

147. Rudziński T., Ciesielczyk M., Religa W. et al. Elderly and patients with sick sinus syndrome have lower chances for appropriate pacemaker mode selection, according to the Polish Cardiac Society recommendations – a single–centre retrospective analysis. // Kardiol Pol. – 2006,Apr. – №64(4). – P.391–395.

148. Sakai Y., Imai S., Sato Y. et al. Clinical and electrophysiological characteristics of binodal disease. // Circ J. – 2006,Dec. – №70(12). – P.1580–1584.

149. Santini M, Alexidou G., Ansalone G. Relation of prognosis in sick sinus syndrome to age, conduction defect and modes of permanent cardiac pacing. // American J. Cardiology№ 65. - P.729.

150. Santini M., Ricci R., Pignalberi C. et al. Is dual defibrillator better than conventional DDD pacing in brady–tachy syndrome? Results of the ICARUS Trial (Internal Cardioversion Antitachypacing and Prevention: Resource Utilization Study). // J Interv Card Electrophysiol. – 2005,Dec.– №14(3). – P.159–168.

151. Sasaki Y., Furihata A., Suyama parison between ventricular inhibited pacing and physiologic pacing in sick sinus syndrome. // American J. Cardiology№ 67. - P. 771.

152. Sastry A., Arnold E., Gurji H. et al. Cardiac–directed expression of adenylyl cyclase VI facilitates atrioventricular nodal conduction. // J Am Coll Cardiol. – 2006,Aug. – vol.1. – №48(3). – P.559–565.

153. Schwaab B., Kindermann M., Schätzer–Klotz D. et al. AAIR versus DDDR pacing in the bradycardia tachycardia syndrome: a prospective, randomized, double–blind, crossover trial. // Pacing Clin Electrophysiol. – 2001,Nov. – №24(11). – P.1585–1595.

154. Sharma AD, Guiraudon GM, Klein GJ, et al. Pacemaker implantation techniques. // Cardiac Pacing and Electrophysiology. N El-Sherif, P Samet (eds.), Philadelphia. – 1991. – P.561–567.

155. Spitzer S. G., Gazarek S., Wacker P. et al. Pacing of the atria in sick sinus syndrome trial: preventive strategies for atrial fibrillation. // Pacing Clin Electrophysiol. – 2003,Jan. – №26(1 Pt 2). – P.268–271.

156. Stockburger M., Trautmann F., Nitardy A. et al. Pacemaker–based analysis of atrioventricular conduction and atrial tachyarrhythmias in patients with primary sinus node dysfunction. // Pacing Clin Electrophysiol. – 2009,May. – №32(5). – P.604–613.

157. Styliadis I. H., Mantziari A. P., Gouzoumas N. I. et al. Indications for permanent pacing and pacing mode prescription from 1989 to 2006. Experience of a single academic centre in Northern Greece. // Hellenic J Cardiol. – 2008,May–Jun. – №49(3). – P.155–162.

158. Sutton R, Bourgeois I. The foundations of cardiac pacing. - Mount Kisko, NY. – 1991.

159. Sutton R, Vardas P. Special surgical techniques in pacemaker implantation. // PACE. – 1987. – 10 – P.750.

160. Sutton R., Kenny R. A. The natural history of sick sinus syndrome. // Pacing Clin Electrophysiol. – 1986,Nov. - №9(6 Pt 2) – P.1110–1114.

161. Sweeney M. O., Bank A. J., Nsah E. et al. Search AV Extension and Managed Ventricular Pacing for Promoting Atrioventricular Conduction (SAVE PACe) Trial. Minimizing ventricular pacing to reduce atrial fibrillation in sinus–node disease. // N Engl J Med. – 2007,Sep. –vol.6. – № 000(10). – P.1000–1008.

162. Sweeney M. O., Hellkamp A. S., Ellenbogen K. A. et al. MOde Selection Trial Investigators. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. // Circulation. – 2003,Jun. – vol.17. – № 000(23). – P.2932–2937.

163. Tang C., Kerr C., Connolly S. Clinical trial of pacing mode selection. // Cardiol. Clin. – 2000. - №18. - P.1-23.

164. Thibault B., Simpson C., Gagné C. E. et al. Impact of AV conduction disorders on SafeR mode performance. // Pacing Clin Electrophysiol. – 2009,Mar. – №32,Suppl 1. – P.231–235.

165. Tse H. F., Xue T., Lau C. P. et al. Bioartificial sinus node constructed via in vivo gene transfer of an engineered pacemaker HCN Channel reduces the dependence on electronic pacemaker in a sick–sinus syndrome model. // Circulation. – 2006,Sep.– vol.5. – № 000(10). –P.1000–1011.

166. Tsurugi T., Abe H., Oginosawa Y. et al. Effects of pacing modes on cardiac baroreflex function in permanently paced patients with sinus node dysfunction. // J Cardiovasc Electrophysiol. – 2008,Jul. – №19(7). – P.702–707.

167. Vardas P., Auricchio A. et al. Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association. European Heart Journal. – 2007. - №28. – P..

168. Vijayvergiya R., Grover A. Acquired atrioventricular block in a patient with sinus node disease on single–chamber atrial pacing. // Indian Heart J. – 2002,Jul–Aug. – №54(4). – P.435–436.

169. Wecke L., Rubulis A., Lundahl G. et al. Right ventricular pacing–induced electrophysiological remodeling in the human heart and its relationship to cardiac memory. // Heart Rhythm. – 2007,Dec. – №4(12). – P.1477–1486.

170. Wiegand U. K. Avoidance of ventricular pacing in patients with sinus node disease or intermittent AV block. // Herzschrittmacherther Elektrophysiol. – 2008,Mar. – №19(1). – P.3–10.

171. Witte J., Knorre G., Volkmann H. Survival rate in patients with sick sinus syndrome in AAI/DDD vs. VVI pacing. // Progress in Clinical Pacing– P.475.

172. Zipes D., Jalife J. Cardiac Electrophysiology: From Cell to Bedside. - WB Saunders company. – 2004. – 1200p.